Skip to content
Kalpvruksh Markets
Offline Log in

VILINBIONSEOffline

VILIN BIO MED · INE0L4V01013
54.55+1.40 (+2.63%)last close · 05 Nov 2026
Prev close
53.15
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
—

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

ESM · surveillance · our estimateWill VILINBIO be put under ESM?
Entry rule met 6-month range, 6-month move — above one standard deviation of companies under ₹1,000 crore and NSE's floor. Stocks newly meeting the rule entered within two weeks 17% of the time; ESM means 100% margin and trade-for-trade.Our estimate, not the exchange’s or the index provider’s. Not advice.

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • FPI +0.1 pp · DII 0.0 pp · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.7×
median 6,000
Delivered
10,000
Of volume
83%

Price & trend

Price & trend

Not enough price historyFigures need 60 sessions of NSE prices.

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters63.6%59.6% −4.156.6% −2.956.6%
FPI0.0%0.0%0.0%0.1% +0.1
Mutual funds————
Other DII0.0%0.0%0.0%0.0%
Individuals34.0%30.2% −3.833.1% +2.933.1%
Others2.4%10.2% +7.810.3%10.1% −0.2

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
384
Individuals
340

Which funds bought and sold

No fund holds this companyNo Indian mutual fund disclosed a position at the last quarter end.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 14 of 14 disclosures
0 selected
29 Dec 2025Karunakar Reddy KundoorPromotersBuy2,07,957₹0.42 cr1.49%Off Market
29 Dec 2025Srinivasa Reddy DevireddyPromotersSell2,07,957₹0.42 cr12.62%Off Market
24 Dec 2025Mohan Rao AdhiPromotersBuy1,44,508₹0.29 cr1.47%Off Market
24 Dec 2025Venkata Rao SadhanalaPromotersSell4,89,463₹0.99 cr8.52%Off Market
22 Dec 2025Shaik SarazPromotersBuy3,44,955₹0.7 cr3.10%Off Market
19 Dec 2025Venkata Rao SadhanalaPromotersSell28,93,360₹5.87 cr12.05%Off Market
19 Dec 2025Pravallika VennaPromotersBuy13,35,400₹2.71 cr9.57%Off Market
19 Dec 2025Allu Ramakrishna ReddyPromotersBuy11,12,830₹2.26 cr7.98%Off Market
19 Dec 2025Venkata Rao SadhanalaPromotersSell28,93,360₹5.87 cr12.05%Off Market
19 Dec 2025Maddula JwalaVeera VenkataPandurangaPraneethPromotersBuy4,45,130₹0.9 cr3.19%Off Market
12 Dec 2025Viswa Prasad SadhanalaPromotersSell7,38,000₹1.5 cr7.96%Off Market
12 Dec 2025Shankar Reddy KatireddyPromotersBuy7,38,000₹1.5 cr5.29%Off Market
12 Dec 2025Viswa Prasad SadhanalaPromotersSell7,38,000₹1.5 cr7.96%Off Market
12 Dec 2025Shankar Reddy KatireddyPromotersBuy7,38,000₹1.5 cr5.29%Off Market

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on September 15, 2026.
    16 Sept 2026
  • Board outcome
    Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on August 10, 2026.
    10 Aug 2026
  • Board outcome
    Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on June 13, 2026.
    15 Jun 2026
  • Board outcome
    Vilin Bio Med Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    01 Jun 2026

VILINBIO: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.